MICA/B+ primary HCC cells isolated from tumor resections were used as target cells in a second set of experiments in which the anti-MICA/B mAb significantly increased PB NK degranulation activity for both allogeneic HCC primary cells in HD and autologous cells in the case of HCC patients (Figure 6B,E). The gene discussed is MICA; the disease is neoplasm.